These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30013398)

  • 1. Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma.
    Zhao L; Chen H; Hu B; Zhang H; Lin Q
    Cancer Manag Res; 2018; 10():1919-1926. PubMed ID: 30013398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy.
    Li Y; Shao Y; Bai L; Zhou X
    Cancer Manag Res; 2018; 10():3841-3847. PubMed ID: 30288115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer.
    Ren K; Yin Y; He F; Shao Y; Wang S
    Cancer Manag Res; 2018; 10():4891-4898. PubMed ID: 30425580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies.
    Pan Y; Si H; Deng G; Chen S; Zhang N; Zhou Q; Wang Z; Dai G
    Front Oncol; 2021; 11():798415. PubMed ID: 35251952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
    Chen S; Guo S; Gou M; Pan Y; Fan M; Zhang N; Tan Z; Dai G
    Front Oncol; 2022; 12():951985. PubMed ID: 36387152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
    Ferrucci PF; Ascierto PA; Pigozzo J; Del Vecchio M; Maio M; Antonini Cappellini GC; Guidoboni M; Queirolo P; Savoia P; Mandalà M; Simeone E; Valpione S; Altomonte M; Spagnolo F; Cocorocchio E; Gandini S; Giannarelli D; Martinoli C
    Ann Oncol; 2016 Apr; 27(4):732-8. PubMed ID: 26802161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.
    Zhou D; Liang J; Xu LI; He F; Zhou Z; Zhang Y; Chen M
    Oncol Lett; 2016 May; 11(5):2987-2994. PubMed ID: 27123051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
    Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
    Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
    Dirican A; Kucukzeybek BB; Alacacioglu A; Kucukzeybek Y; Erten C; Varol U; Somali I; Demir L; Bayoglu IV; Yildiz Y; Akyol M; Koyuncu B; Coban E; Ulger E; Unay FC; Tarhan MO
    Int J Clin Oncol; 2015 Feb; 20(1):70-81. PubMed ID: 24532163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma.
    Song S; Chen H; Dong W; Zhou H
    Acta Otolaryngol; 2019 Mar; 139(3):294-298. PubMed ID: 30882257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
    Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
    Zhou X; Sun X; Zhao W; Fang X; Wang X
    Cancer Manag Res; 2019; 11():4243-4254. PubMed ID: 31190991
    [No Abstract]   [Full Text] [Related]  

  • 13. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
    Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
    Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
    Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
    Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors.
    Mullally WJ; Greene J; Jordan EJ; Horgan AM; O'Connor M; Calvert PM
    Ir J Med Sci; 2023 Feb; 192(1):83-87. PubMed ID: 35304710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer.
    Liu F; Luo H; Zhu Z; Zhu P; Huang J
    J Cell Physiol; 2019 Dec; 234(12):22775-22786. PubMed ID: 31140613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer.
    Yucel S; Bilgin B
    J Oncol Pharm Pract; 2021 Jan; 27(1):71-77. PubMed ID: 32248739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
    Li S; Zou J; Liu C; Jiao X; Gong J; Li J; Wang Z; Lu M; Lu Z; Shen L
    Clin Immunol; 2020 Mar; 212():108345. PubMed ID: 31953149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
    Alessi JV; Ricciuti B; Alden SL; Bertram AA; Lin JJ; Sakhi M; Nishino M; Vaz VR; Lindsay J; Turner MM; Pfaff K; Sharma B; Felt KD; Rodig SJ; Gainor JF; Awad MM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.